American Academy of Ophthalmology

A review of over 13,000 newly-diagnosed DME patients found that about 75% received no treatment in the first 28 days since diagnosis.

Vision loss patients may be 3 times as likely to suffer from major depressive symptoms than the general population.

The mortality rate of AMD patients who received a bevacizumab injection 3 or 6 months after stroke was, in the study’s words, “worrying” compared to the rate of those who did not.

Explaining diabetic macular edema to patients can be a challenge in itself. Going further to explain the injection process can take even more care for eye care professionals.

Difluprednate, a steroid stronger than prednisolone, was recently tested for treatment of macular edema and vitritis in cases of posterior/intermediate uveitis, and its impact was noticeable.